prof. dr. Piet Ost
- ORCID iD
- 0000-0002-2203-4848
Show
Sort by
-
Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)
-
- Journal Article
- A1
- open access
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
-
- Journal Article
- A1
- open access
TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment
-
- Journal Article
- A1
- open access
The efficacy and safety of metastasis-directed therapy in patients with prostate cancer : a systematic review and meta-analysis of prospective studies
-
- Journal Article
- A1
- open access
Stereotactic body and conventional radiotherapy for painful bone metastases : a systematic review and meta-analysis
-
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
-
- Journal Article
- A1
- open access
Incidence and radiotherapy treatment patterns of complicated bone metastases
-
Docetaxel provides oncological benefits in the era of new-generation androgen receptor inhibitors : or is three a crowd?
-
Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial
-
- Journal Article
- A1
- open access
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort